Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Repurposing of the Approved Small Molecule Drugs in Order to Inhibit Sars-Cov-2 S Protein and Human Ace2 Interaction Through Virtual Screening Approaches
Ahmadreza Niavarani
Ahmadreza Niavarani

Associate Professor of Biologic Products

Shariati Hospital

Digestive Diseases Research Center

Tehran University of Medical Sciences

All Documents
1. Genome-Wide Association Study of Long Covid, Nature Genetics (2025)
2. The Role of Distinct Apobec/Adar Mrna Levels in Mutational Signatures Linked to Aging and Ultraviolet Radiation, Scientific Reports (2024)
3. A First Update on Mapping the Human Genetic Architecture of Covid-19, Nature (2022)
4. Molecular Dynamics Analysis Predicts Ritonavir and Naloxegol Strongly Block the Sars-Cov-2 Spike Protein-Hace2 Binding, Journal of Biomolecular Structure and Dynamics (2022)
5. Seroprevalence of Sars-Cov-2 Antibody Among Urban Iranian Population: Findings From the Second Large Population-Based Cross-Sectional Study, BMC Public Health (2022)
6. The Long-Term Outcome and Efficacy of Pr1/Bcr-Abl Multipeptides Vaccination in Chronic Myeloid Leukemia: Results of a 7-Year Longitudinal Investigation, Iranian Journal of Blood and Cancer (2022)
7. Whole-Genome Sequencing Reveals Host Factors Underlying Critical Covid-19, Nature (2022)
8. Dynamics of the Covid-19 Clinical Findings and the Serologic Response, Frontiers in Microbiology (2021)
9. Mutational Signatures in Esophageal Squamous Cell Carcinoma From Eight Countries With Varying Incidence, Nature Genetics (2021)
10. Sars-Cov-2 Antibody Seroprevalence in the General Population and High-Risk Occupational Groups Across 18 Cities in Iran: A Population-Based Cross-Sectional Study, The Lancet Infectious Diseases (2021)
11. Sars-Cov-2 Antibody Seroprevalence in the General Population and High-Risk Occupational Groups Across 18 Cities in Iran: A Population-Based Cross-Sectional Study, The Lancet Infectious Diseases (2021)
12. Pancancer Analysis Identifies Prognostic High-Apobec1 Expression Level Implicated in Cancer In-Frame Insertions and Deletions, Carcinogenesis (2018)
13. A 4-Gene Expression Score Associated With High Levels of Wilms Tumor-1 (Wt1) Expression Is an Adverse Prognostic Factor in Acute Myeloid Leukaemia, British Journal of Haematology (2016)
14. The Wilms Tumor-1 (Wt1) Rs2234593 Variant Is a Prognostic Factor in Normal Karyotype Acute Myeloid Leukemia, Annals of Hematology (2016)
15. Apobec3a Is Implicated in a Novel Class of G-To-A Mrna Editing in Wt1 Transcripts, PLoS ONE (2015)